Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension

Published:2018-02-22 Issue:5 Volume:48 Page:874-884
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Blum Lisa K.¹²^ORCID,Cao Richard R.L.¹,Sweatt Andrew J.³,Bill Matthew³,Lahey Lauren J.¹²,Hsi Andrew C.³,Lee Casey S.¹²,Kongpachith Sarah¹²,Ju Chia-Hsin¹²,Mao Rong¹²,Wong Heidi H.¹,Nicolls Mark R.²³,Zamanian Roham T.³,Robinson William H.¹²

Affiliation:

1. Stanford University School of Medicine; Division of Immunology and Rheumatology; Stanford CA USA

2. VA Palo Alto Health Care System; Palo Alto CA USA

3. Stanford University Medical Center; Division of Pulmonary and Critical Care Medicine; Stanford CA USA

Funder

Vera Moulton Wall Center for Pulmonary Vascular Diseases

National Institutes of Health

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Pulmonary arterial hypertension associated to connective tissue diseases;Galie;Lupus,2005

2. Prevalence and incidence of pulmonary hypertension among HIV-infected people in Africa: a systematic review and meta-analysis;Bigna;BMJ Open,2016

3. Mechanisms of disease: pulmonary arterial hypertension;Schermuly;Nat. Rev. Cardiol.,2011

4. Causes and circumstances of death in pulmonary arterial hypertension;Tonelli;Am. J. Respir. Crit. Care Med.,2013

5. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension;Rabinovitch;Circ. Res.,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension;Journal of Chemotherapy;2024-05-08

2. B-cells in pulmonary arterial hypertension: friend, foe or bystander?;European Respiratory Journal;2024-03-14

3. Molecular and immunological basis of pulmonary arterial hypertension and pulmonary veno-occlusive disease;Genomic and Molecular Cardiovascular Medicine;2024

4. Immune monitoring of patients treated with anti-CD20 therapeutic monoclonals for autoimmune disorders;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

5. An optimized machine learning method for predicting wogonin therapy for the treatment of pulmonary hypertension;Computers in Biology and Medicine;2023-09